Consortia to Advance Collaboration in Epidemiologic and Cancer Research
- EGRP's Definition of Consortia
- NCI Cohort Consortium
- Cancer Epidemiology Consortia
- Additional Research Consortia
- Role of EGRP in Consortia
- Data Sharing Expectations for Consortia
EGRP's Definition of Consortia
The National Cancer Institute's (NCI) Epidemiology and Genomics Research Program (EGRP) defines a consortium as a group of scientists from multiple institutions who have agreed to participate in cooperative research efforts involving activities such as methods development and validation, pooling of information from more than one study for the purpose of combined analyses, and collaborative projects. Consortia are able to address scientific questions that cannot be addressed otherwise due to scope, resources, population size, or expertise. This cooperation usually involves multiple projects over an extended period of time. Consortia can also be referred to as collaboratives.
The creation of a consortium is independent from NCI and NIH funding mechanisms. Groups participating in a consortium may partner in the writing of research grant applications, but consortium activities are not limited to a specific grant/project.
For sources of support, view our compilation of NCI and NIH funding opportunities that are relevant to cancer epidemiology or contact an EGRP Program Director.
NCI Cohort Consortium
The NCI Cohort Consortium is an extramural-intramural partnership formed by NCI to address the need for large-scale collaborations to pool the large quantity of data and biospecimens necessary to conduct a wide range of cancer studies. The Consortium, through its collaborative network of investigators, provides a coordinated, interdisciplinary approach to tackling important scientific questions, economies of scale, and opportunities to quicken the pace of research.
The mission of the NCI Cohort Consortium is to:
- Foster communication among investigators leading cohort studies of cancer;
- Promote collaborative research projects for topics not easily addressed in a single study; and
- Identify common challenges in cohort research and search for solutions.
The NCI Cohort Consortium includes investigators responsible for more than 50 high-quality cohorts involving more than 7 million people. The cohorts are international in scope and cover large, rich, and diverse populations. Extensive risk factor data are available on each cohort, and biospecimens including germline DNA collected at baseline, are available on approximately 2 million individuals. Investigators team up to use common protocols and methods, and to conduct coordinated parallel and pooled analyses.
Cancer Epidemiology Consortia
The list below provides links to information about research consortia that may be of interest to cancer epidemiologists. It is not an exhaustive list. Access to resources is dependent on procedures outlined for each individual consortium. Consortia interested in being included in this list should contact NCIEpiConsortia@mail.nih.gov.
- Bladder Cancer
- International Consortium of Bladder Cancer (ICBC)
- Brain Cancer
- Brain Tumor Epidemiology Consortium (BTEC)
- GLIOGENE
- Pediatric Brain Tumor Consortium (PBTC)
- Breast Cancer
- African-American Breast Cancer Consortium
- Asian Breast Cancer Consortium (ABCC)
- Breast Cancer Association Consortium (BCAC)
- Breast Cancer Consortium for Outcomes And Survival (BC2OS)
- Breast Cancer Family Registry (B-CFR)
- Consortium of Contralateral Breast Cancer (CCBC)
- The Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
- Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium (ENIGMA)
- Lessons in Epidemiology and Genetics of Adult Cancer from Youth (LEGACY): a Cohort of Youth in Families from the Breast Cancer Family Registry
- Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers)
- Women, Cancer and Radiation Exposure (WECARE)
- Childhood Cancers
- Childhood Leukemia International Consortium (CLIC)
- International Childhood Cancer Cohort Consortium (I4C)
- Pediatric Brain Tumor Consortium
- Colorectal Cancer
- African coloRectal cancer GrOup (ARGO)
- Asian Colorectal Cancer Consortium (ACCC)
- Colon Cancer Family Registry (C-CFR)
- Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO)
- Lynch Syndrome Screening Network (LSSN)
- Endometrial Cancer
- Epidemiology of Endometrial Cancer Consortium (E2C2)
- Esophageal Cancer
- Asian Barrett's Consortium
- International Barrett's and Esophageal Adenocarcinoma Consortium (BEACON)
- Head and Neck Cancer
- International Head and Neck Cancer Epidemiology Consortium (INHANCE)
- Kidney Cancer
- International Consortium for Investigation of Inherited Renal Malignancies (I-ConFIRM)
- Leukemia
- Childhood Leukemia International Consortium (CLIC)
- Chronic Lymphocytic Leukemia Research Consortium (CRC)
- Liver
- Hepatocellular Carcinoma Epidemiology Consortium (HCCEC)
- Lung Cancer
- Genetic Epidemiology of Lung Cancer (GELCC)
- International Lung Cancer Consortium (ILCCO)
- Lymphoma
- International Lymphoma Epidemiology Consortium (InterLymph)
- Ovarian Cancer
- Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium (ENIGMA)
- Ovarian Cancer Association Consortium (OCAC)
- Ovarian Cancer Cohort Consortium (OC3)
- Ovarian Cancer in Women of African Ancestry (OCWAA)
- Pacific Ovarian Cancer Research Consortium (POCRC)
- Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers)
- Pancreatic Cancer
- Pancreatic Cancer Case Control Consortium (PANC4)
- Pancreatic Cancer Cohort Consortium
- Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE)
- Prostate Cancer
- Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in BRCA1 and BRCA2 mutation carriers and controls (IMPACT)
- International Consortium on Prostate Cancer Genetics (ICPCG)
- Men of African Descent and Prostate Cancer (MADCaP)
- Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL)
- Prostate Cancer Transatlantic Consortium (CaPTC)
- Skin Cancers
- Genes, Environment and Melanoma (GEM)
- Keratinocyte Carcinoma Consortium (KeraCon)
- Melanoma Genetics Consortium (GenoMEL)
- Testicular Cancer
- Testicular Cancer Consortium (TECAC)
- Multiple Cancers
- African-Caribbean Cancer Consortium (AC3)
- Asia Cohort Consortium
- Cancer Genetics Network (CGN)
- Clinical Cancer Genetics Community Research Network (CCGCRN)
- Comprehensive Oncologic Emergencies Research Network (CONCERN)
- Latin American Cancer Epidemiology Consortium (LACE)
- Li-Fraumeni Exploration Consortium (LiFE)
- NCI Cohort Consortium
- Radiogenomics Consortium (RGC)
- EGRP - Epidemiology and Genomics Research Program
- CDC - Centers for Disease Control and Prevention
- DCB - Division of Cancer Biology
- DCEG - Division of Cancer Epidemiology and Genetics
- NCI - National Cancer Institute
- NHGRI - National Human Genome Research Institute
- NIEHS - National Institute of Environmental Health Sciences
- NIGMS - National Institute of General Medical Sciences
- NIH - National Institutes of Health
- OCS - Office of Cancer Survivorship
- OD - Office of the Director
Additional Research Consortia
A number of additional research consortia conduct research to better understand determinants of various health outcomes in human populations, which may influence cancer risk. Some of the collaborations in which EGRP staff participate include:
- COnsortium of METabolomics Studies (COMETS)
- Dietary Patterns Methods Project (DPMP)
- Metabolomics Quality Assurance and Quality Control Consortium (mQACC)
- Multi-cohort Eating and Activity Study for Understanding Reporting Error (MEASURE)
- Obesity Policy Research Grantees Network
- Sensor Methods Collaboratory
- Validation Studies Pooling Project (VSPP)
Role of EGRP in Consortia
EGRP fosters consortia through the following activities:
- Advising investigators on the formation of new consortia
- Advising consortia on policies and processes related to funding, data sharing, and collaborations
- As appropriate, participating on steering or executive committees or working groups.
Questions about EGRP and Consortia can be sent to NCIEpiCommunications@mail.nih.gov.
Data Sharing Expectations for Consortia
EGRP supports compliance with the NIH Data Sharing Policy and Genomic Data Sharing Policy. Data sharing is essential for expedited translation of research results into knowledge, products, and procedures to improve human health. To help investigators comply with these policies, NCI and NIH support a number of data repositories to help facilitate efficient data sharing, including the database of Genotypes and Phenotypes (dbGaP).
African-American Breast Cancer Consortium
Since 2008
NIH ContactsEGRP/NCI:
Consortium Liaison:
Damali Martin, Ph.D., M.P.H.
Lead Investigators:
Chris Haiman, Ph.D.
Norris Comprehensive Cancer Center,
University of Southern California
Funmi Olopade, M.D.
The University of Chicago
Julie Palmer, Sc.D.
Boston University
Asian Breast Cancer Consortium (ABCC)
Since 2008
NIH ContactsEGRP/NCI:
ABCC Liaison:
Gabriel Lai, Ph.D.
Lead Investigator:
Wei Zheng, M.D., Ph.D.
Vanderbilt University School of Medicine
University of Southern California
African-Caribbean Cancer Consortium (AC3)
Since 2006
NIH ContactsEGRP/NCI:
AC3 Liaison:
Damali Martin, Ph.D., M.P.H.
Lead Investigator:
Camille Ragin Ph.D., M.P.H.
Fox Chase Cancer Center
Asian Colorectal Cancer Consortium (ACCC)
Since 2008
NIH ContactsEGRP/NCI:
ACCC Liaison:
Gabriel Lai, Ph.D.
Lead Investigator:
Wei Zheng, M.D., Ph.D.
Vanderbilt University School of Medicine
University of Southern California
African coloRectal cancer GrOup (ARGO)
Since 2013
NIH ContactsEGRP/NCI:
EGRP Liaison:
Krista Zanetti, Ph.D., M.P.H., R.D.
Lead Investigators:
Isaac Alatise, M.D.
Obafemi Awolowo University Teaching Hospital
Ile Ife, Nigeria
Peter Kingham, M.D.
Memorial Sloan Kettering Cancer Center
Asian Cohort Consortium
Since 2004
NIH ContactsLead Investigators:
John Potter M.D. Ph.D.
Fred Hutchinson Cancer Research Center
Daehee Kang, M.D., Ph.D.
Seoul National University College of Medicine, Korea
Asian Barrett's Consortium
Since 2008
NIH ContactsLead Investigator:
Lawrence Ho, M.B.B.S., M.D., F.R.A.C.P., F.A.M.S., F.R.C.P.
National University of Singapore
Breast Cancer Consortium for Outcomes And Survival (BC2OS)
Since 2007
NIH ContactsLead Investigator:
Larry Kushi
Kaiser Foundation Research Institute
Breast Cancer Association Consortium (BCAC)
Since 2005
Visit Consortium Website
NIH Contacts
EGRP/NCI:
BCAC Liaison:
Lisa Gallicchio, Ph.D.
Stefanie Nelson, Ph.D.
Lead Investigators:
Douglas Easton, Ph.D.
University of Cambridge
Paul Pharoah, Ph.D.
Cambridge Cancer Center
Georgia Chenevix-Trench, Ph.D.
Queensland Institute of Medical Research
Manjeet Humphreys
University of Cambridge
Breast Cancer Family Registry (B-CFR)
Since 1995
NIH ContactsEGRP/NCI:
B-CFR Liaison:
Scott Rogers, M.P.H. (for Informatics)
Lead Investigators:
Irene Andrulis, Ph.D.
Cancer Care Ontario
Saundra Buys, M.D.
University of Utah Health Sciences Center
Mary Daly, M.D., Ph.D.
Fox Chase Cancer Center
John Hopper, Ph.D.
University of Melbourne
Esther John, Ph.D., M.S.P.H.
Cancer Prevention Institute of California
Mary Beth Terry, Ph.D.
Columbia University
International Barrett's and Esophageal Adenocarcinoma Consortium (BEACON)
Since 2005
NIH ContactsLead Investigator:
Includes various EGRP-supported investigators teamed with DCEG investigators.
Brain Tumor Epidemiology Consortium (BTEC)
Since 2003
NIH ContactsLead Investigators:
Luc Bauchet, M.D., Ph.D.
Centre Hospitalo-Universitaire (CHU) and National Institute of Health and Medical Research (INSERM), Montpellier, France
Joe Wiemels, Ph.D.
University of California, San Francisco
Prostate Cancer Transatlantic Consortium (CaPTC)
Since 2005
NIH ContactsEGRP/NCI:
CaPTC Liaison:
Damali Martin, Ph.D., M.P.H.
Lead Investigator:
Folakemi T. Odedina, Ph.D.
University of Florida College of Pharmacy and Shands Cancer Center
Consortium of Contralateral Breast Cancer (CCBC)
Since 2011
NIH ContactsEGRP/NCI:
CCBC Liaison:
Joanne Elena, Ph.D., M.P.H.
Lead Investigator:
Jonine Bernstein, Ph.D.
Memorial Sloan-Kettering Cancer Center
Colon Cancer Family Registry (C-CFR)
Since 1997
NIH ContactsEGRP/NCI:
C-CFR Liaison:
Scott Rogers, M.P.H. (for Informatics)
Lead Investigators:
Robert Haile, Dr.P.H.
Stanford University
Noralane (Laney) Lindor, M.D.
Mayo Clinic
Steve Gallinger, M.D.
Mount Sinai Hospital
Cancer Care Ontario
John Hopper, Ph.D.
University of Melbourne
Loic Le Marchand, M.D., Ph.D.
University of Hawaii at Manoa
Polly Newcomb, Ph.D., M.P.H.
Fred Hutchinson Cancer Research Center
Clinical Cancer Genetics Community Research Network (CCGCRN)
Since 2014
NIH ContactsEGRP/NCI:
CCGCRN Liaison:
Nonniekaye Shelburne, C.R.N.P., M.S., A.O.C.N.
Lead Investigator:
Jeff Weitzel, M.D.
City of Hope
Research Administrator:
Sharon Sand, C.C.R.P.
City of Hope
Cancer Genetics Network (CGN)
Since 1998
NIH ContactsEGRP/NCI:
CGN Liaison:
Scott Rogers, M.P.H.
Lead Investigator:
Dianne L. Finkelstein, Ph.D.
Massachusetts General Hospital
The Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Since 2005
NIH ContactsEGRP/NCI:
CIMBA Liaison:
Damali Martin, Ph.D., M.P.H.
Lead Investigators:
Georgia Chenevix-Trench, Ph.D.
Queensland Institute of Medical Research
Douglas Easton, Ph.D.
University of Cambridge
Timothy Rebbeck, Ph.D.
Harvard University
Childhood Leukemia International Consortium (CLIC)
Since 2006
NIH ContactsEGRP/NCI:
CLIC Liaison:
Somdat Mahabir, Ph.D., M.P.H.
Lead Investigator:
Catherine Metayer, M.D., Ph.D.
University of California, Berkley
Project Manager:
Alice Kang
University of California, Berkley
Chronic Lymphocytic Leukemia Research Consortium (CRC)
Since 2006
NIH ContactsLead Investigator:
Includes various EGRP-funded investigators teamed with DCEG investigators.
Thomas Kipps, Ph.D., M.D.
University of California, San Diego
Manager
Andrew W. Greaves
University of California, San Diego
NCI Cohort Consortium
Since 2000
NIH ContactsLead Investigators:
Elio Riboli, M.D., M.P.H., M.Sc. (Chair)
Imperial College
Leslie Bernstein, Ph.D.
City of Hope National Medical Center and Beckman Research Institute
William J. Blot, Ph.D.
Vanderbilt University and International Epidemiology Institute, Ltd.
Susan Gapstur, Ph.D., M.P.H.
American Cancer Society, Inc.
Mattias Johansson, Ph.D.
International Agency for Research on Cancer (IARC/WHO)
Meir Stampfer, M.D, Dr. P.H.
Harvard Medical School, Harvard School of Public Health, and Brigham and Women's Hospital
Anthony Swerdlow, Ph.D., M.P.H.
University of London, Institute of Cancer Research
Wei Zheng, M.D., Ph.D., M.P.H.
Vanderbilt University Medical Center
Comprehensive Oncologic Emergencies Research Network (CONCERN)
Since 2015
NIH ContactsLead Investigators:
Jeff Caterino, M.D.
The Ohio State University
Corita Grudzen, M.D.
NYU Langone Medical Center
Demetrious (Jim) Kyriacou, M.D., Ph.D.
Northwestern University
Epidemiology of Endometrial Cancer Consortium (E2C2)
Since 2006
NIH ContactsLead Investigator:
Sara Olson, Ph.D.
Memorial Sloan-Kettering Cancer Center
Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium (ENIGMA)
Since 2009
NIH ContactsEGRP/NCI:
ENIGMA Liaison:
Melissa Rotunno, Ph.D.
Lead Investigator:
David Goldgar, Ph.D.
University of Utah
Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO)
Since 2008
NIH ContactsEGRP/NCI:
GECCO Liaison:
Leah Mechanic, Ph.D., M.P.H.
Lead Investigator:
Ulrike Peters, Ph.D., M.P.H.
University of Washington School of Public Health
Genetic Epidemiology of Lung Cancer (GELCC)
Since 1999
NIH ContactsLead Investigator:
Marshall Anderson, Ph.D.
University of Cincinnati
Genes, Environment and Melanoma (GEM)
Since 1999
NIH ContactsEGRP/NCI:
GEM Liaison:
Damali Martin, Ph.D., M.P.H.
Lead Investigator:
Marianne Berwick, Ph.D., M.P.H.
University of New Mexico
Melanoma Genetics Consortium (GenoMEL)
Since 1997
NIH ContactsLead Investigators:
Peter Kanetsky
Moffitt Cancer Center
Julia Newton-Bishop, M.D.
Leeds Cancer Centre at St James's University Hospital, England
GLIOGENE
Since 2007
NIH ContactsEGRP/NCI:
GLIOGENE Liaison:
Melissa Rotunno, Ph.D.
Lead Investigator:
Melissa Bondy, Ph.D.
Baylor College of Medicine
Hepatocellular Carcinoma Epidemiology Consortium (HCCEC)
Since 2011
NIH ContactsEGRP/NCI:
HCC Liaison:
Gabriel Lai, Ph.D.
Lead Investigators:
Manal M. Hassan, M.B. B.C.H., M.P.H., Ph.D.
University of Texas M.D. Anderson Cancer Center
Hashem B. El-Serag, M.D., M.P.H.
Baylor College of Medicine
International Childhood Cancer Cohort Consortium (I4C)
Since 2005
NIH ContactsLead Investigator:
Includes various EGRP-funded investigators teamed with DCEG investigators.
Terry Dwyer, A.O., M.D., M.P.H.
Murdoch Childrens Research Institute, Melbourne
International Consortium of Bladder Cancer (ICBC)
Since 2005
NIH ContactsLead Investigator:
Xifeng Wu, M.D., Ph.D.
The University of Texas M. D. Anderson Cancer Center
International Consortium for Investigation of Inherited Renal Malignancies (I-ConFIRM)
Since 2013
NIH ContactsEGRP/NCI:
I-ConFIRM Liaison:
Krista A. Zanetti, Ph.D., M.P.H., R.D.
Lead Investigators:
Gianluca Severi, Ph.D.
Centre for Research in Epidemiology and Population Health, INSERM, Paris South University
Eamonn Maher, B.Sc., M.D., F.R.C.P., F.Med.Sci.
University of Cambridge
Loren Lipworth, Sc.D.
Vanderbilt University
Fiona Bruinsma, Dr.P.H.
Cancer Council Victoria
Ingrid Winship, M.B.Ch.B., M.D., F.R.A.C.P., F.A.C.D., F.A.I.C.D.
University of Melbourne
International Consortium on Prostate Cancer Genetics (ICPCG)
Since 1996
NIH ContactsLead Investigator:
Includes various EGRP-funded investigators teamed with NHGRI investigators.
Stephen N. Thibodeau, Ph.D.
Mayo Clinic
International Lung Cancer Consortium (ILCCO)
Since 2004
NIH ContactsLead Investigator:
Rayjean J. Hung, Ph.D., M.S.
Samuel Lunenfeld Research Institute
Cancer Care Ontario
Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in BRCA1 and BRCA2 mutation carriers and controls (IMPACT)
Since 2005
NIH ContactsEGRP/NCI:
IMPACT Liaison:
Rao L. Divi, Ph.D.
Lead Investigator:
Rosalind Eeles, Ph.D.
The Institute of Cancer Research, UK
International Head and Neck Cancer Epidemiology Consortium (INHANCE)
Since 2004
NIH ContactsDCCPS/NCI:
INHANCE Liaison:
Gabriel Lai, Ph.D.
Deborah M. Winn, Ph.D.
Lead Investigators:
Mia Hashibe, M.P.H., Ph.D.
University of Utah School of Medicine
International Lymphoma Epidemiology Consortium (InterLymph)
Since 2001
NIH ContactsLead Investigators:
Alexandra Nieters, Ph.D.
Head of Clinical Research Unit
Center for Chronic Immunodeficiency
Medical Center - University of Freiburg
Sophia Wang, Ph.D.
Associate Professor
Cancer Etiology
City of Hope
Claire Vajdic, Ph.D.
Cancer Aetiology and Prevention Group
Prince of Wales Clinical School
University of New South Wales, Australia
Keratinocyte Carcinoma Consortium (KeraCon)
Since 2014
NIH ContactsEGRP/NCI:
KeraCon Liaison:
Gabriel Lai, Ph.D.
Lead Investigators:
Martin Weinstock, M.D., Ph.D.
Brown University
Leah Ferrucci, Ph.D., M.P.H.
Yale School of Public Health
Latin American Cancer Epidemiology Consortium (LACE)
Since 2008
NIH ContactsEGRP/NCI:
LACE Liaison:
Tram Kim Lam, Ph.D., M.P.H.
NCI/OD
Jorge Gomez, M.D., Ph.D.
Office of Latin American Cancer Program Development
Lead Investigators:
Robert Haile, Dr.P.H.
Stanford University
Lessons in Epidemiology and Genetics of Adult Cancer from Youth (LEGACY): a Cohort of Youth in Families from the Breast Cancer Family Registry
Since 2011
NIH ContactsEGRP/NCI:
LEGACY Liaison:
Gabriel Lai, Ph.D.
Lead Investigators:
Esther M. John, Ph.D., M.S.P.H.
Cancer Prevention Institute of California
Mary Beth Terry, Ph.D.
Columbia University Medical Center
Mary B. Daly, M.D., Ph.D.
Fox Chase Cancer Center
Irene L. Andrulis, Ph.D.
Samuel Lunenfeld Research Institute, Mt. Sinai Hospital
Saundra Buys, M.D.
Huntsman Cancer Institute
Li-Fraumeni Exploration Consortium (LiFE)
Since 2010
NIH ContactsLead Investigators:
David Malkin, M.D.
University of Toronto
Judy Garber, M.D., M.P.H.
Dana-Farber Cancer Institute
Louise Strong, M.D.
The University of Texas M.D. Anderson Cancer Center
Pierre Hainaut, Ph.D.
International Agency for Research on Cancer
Maria Isabel Achatz, M.D., Ph.D.
Hospital A.C. Carmargo-Fundação Antonio Prudente, São Paulo, Brazil
Lynch Syndrome Screening Network (LSSN)
Since 2011
NIH ContactsEGRP/NCI:
LSSN Liaison:
Nonniekaye Shelburne, C.R.N.P., M.S., A.O.C.N.
Lead Investigators:
Debra Duquette, M.S., C.G.C.
Michigan Department of Community Health
Sarah Mange, M.P.H.
Michigan Deptartment of Community Health
Cecelia A. Bellcross, Ph.D., M.S., C.G.C.
Emory University School of Medicine
Kory Jasperson, M.S., C.G.C.
Huntsman Cancer Institute
Heather Hampel, M.S., C.G.C.
Ohio State University
Men of African Descent and Prostate Cancer (MADCaP)
Since 2007
NIH ContactsLead Investigator:
Timothy Rebbeck, Ph.D.
Harvard University
Ovarian Cancer Cohort Consortium (OC3)
Since 2009
NIH ContactsLead Investigators:
Shelley Tworoger, Ph.D.
Harvard University School of Public Health
Alan Arslan, M.D.
New York University
Ovarian Cancer Association Consortium (OCAC)
Since 2005
NIH ContactsEGRP/NCI:
OCAC Liaison:
Lisa Gallicchio, Ph.D.
Stefanie Nelson, Ph.D.
Lead Investigator:
Andrew Berchuck, M.D.
Duke University Comprehensive Cancer Center
Ovarian Cancer in Women of African Ancestry (OCWAA)
Since 2013
NIH ContactsEGRP/NCI:
OCWAA Liaison:
Krista A. Zanetti, Ph.D., M.P.H., R.D.
Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE)
Since 2002
NIH ContactsEGRP/NCI:
PACGENE Liaison:
Gabriel Lai, Ph.D.
Lead Investigator:
Gloria Petersen, Ph.D.
Mayo Clinic
Pancreatic Cancer Case Control Consortium (PANC4)
NIH Contacts
EGRP/NCI:
PANC4 Liaison:
Gabriel Lai, Ph.D.
Lead Investigator:
Gloria Petersen, Ph.D.
Mayo Clinic
Pancreatic Cancer Cohort Consortium
Since 2006
NIH ContactsLead Investigator:
Charles Fuchs, M.D., M.P.H.
Harvard University
Pediatric Brain Tumor Consortium (PBTC)
Since 1999
NIH ContactsLead Investigator:
Includes various EGRP-funded investigators teamed with DCEG investigators.
Patricia Buffler, Ph.D, M.P.H.
University of California, Berkeley
Pacific Ovarian Cancer Research Consortium (POCRC)
Since 1999
NIH ContactsEGRP/NCI:
POCRC Liaison:
Tram Kim Lam, Ph.D., M.P.H.
Lead Investigator:
Nicole Urban, Ph.D.
University of Washington School of Public Health
Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL)
Since 2007
NIH ContactsEGRP/NCI:
PRACTICAL Liaison:
Danielle Daee, Ph.D.
Lead Investigators:
Rosalind Eeles, Ph.D.
The Institute of Cancer Research, UK
Zsofia Kote-Jarai, Ph.D.
The Institute of Cancer Research, UK
Douglas Easton, Ph.D.
University of Cambridge and Cancer Research UK
Sara Benlloch Garcia (Coordinator)
University of Cambridge
Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers)
EGRP/NCI:
PROSE Liaison:
Rao L. Divi, Ph.D.
Lead Investigators:
Timothy Rebbeck, Ph.D.
Harvard University
Radiogenomics Consortium (RGC)
Since 2009
NIH ContactsEGRP/NCI:
Radiogenomics Consortium Liaison:
Nonniekaye Shelburne, C.R.N.P., M.S., A.O.C.N.
DCEG/NCI:
Lead Investigators:
Barry Rosenstein, Ph.D.
Mount Sinai School of Medicine
Catharine West, Ph.D.
University of Manchester School of Medicine
Testicular Cancer Consortium (TECAC)
Since 2012
NIH ContactsEGRP/NCI:
TECAC Liaison:
Armen Ghazarian, Ph.D., M.P.H.
Krista A. Zanetti, Ph.D., M.P.H., R.D.
Lead Investigator:
Stephen M. Schwartz, Ph.D.
Fred Hutchinson Cancer Research Center
Women, Cancer and Radiation Exposure (WECARE)
Since 2002
NIH ContactsEGRP/NCI:
WECARE Liaison:
Gabriel Lai, Ph.D.
Lead Investigators:
Jonine Bernstein, Ph.D.
Memorial Sloan-Kettering Cancer Center